Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vivek Subbiah

Showing results (31-40 of 487) with videos related to

Pageof 49
Sort By:
European Journal of Cancer (Oxford, England : 1990)|May 9, 2026
The case for tumour-agnostic reimbursement of dual immunotherapyVivek Subbiah, Razelle Kurzrock
Current Opinion in Oncology|April 27, 2011
Phase 1 clinical trials for sarcomas: the cutting edgeVivek Subbiah, Razelle Kurzrock
Sarcoma|November 6, 2010
Targeted Therapy of Ewing's SarcomaVivek Subbiah, Pete Anderson
Nature Medicine|September 10, 2025
Critical evaluation of the ProfiLER-02 study design and outcomesVivek Subbiah, Razelle Kurzrock
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2025
Precision Oncology and Modernizing Evidence Standards: A Critical Commentary on the Cochrane ReviewVivek Subbiah, Razelle Kurzrock
Journal of Medical Case Reports|April 11, 2008
Elevated maternal lipoprotein (a) and neonatal renal vein thrombosis: a case reportVivek Subbiah, Prabhu Parimi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2023
Reply to S. SorscherVivek Subbiah, Razelle Kurzrock
BMJ Case Reports|May 8, 2019
Molecular imaging of metastatic atrial angiosarcoma with positron emission tomography (PET) tracer 3'-deoxy-3'[<sup>(18)</sup>F]-fluorothymidine, [<sup>(18)</sup>F]-FLT imaging and early response evaluationKalevi Kairemo, Vivek Subbiah
Journal of Immunotherapy and Precision Oncology|June 6, 2022
COVID-19 Pandemic and Cancer Clinical Trial Pandemonium: Finding the Silver LiningAakash Desai, Vivek Subbiah
Nature Reviews. Clinical Oncology|January 27, 2025
Transforming paediatric AML trials: from failing one-size-fits-all methods to precision oncologyBranko Cuglievan, Vivek Subbiah
Pageof 49

Showing results (31-40 of 487) with videos related to

Sort By:
Pageof 49
European Journal of Cancer (Oxford, England : 1990)|May 9, 2026
The case for tumour-agnostic reimbursement of dual immunotherapyVivek Subbiah, Razelle Kurzrock
Current Opinion in Oncology|April 27, 2011
Phase 1 clinical trials for sarcomas: the cutting edgeVivek Subbiah, Razelle Kurzrock
Sarcoma|November 6, 2010
Targeted Therapy of Ewing's SarcomaVivek Subbiah, Pete Anderson
Nature Medicine|September 10, 2025
Critical evaluation of the ProfiLER-02 study design and outcomesVivek Subbiah, Razelle Kurzrock
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2025
Precision Oncology and Modernizing Evidence Standards: A Critical Commentary on the Cochrane ReviewVivek Subbiah, Razelle Kurzrock
Journal of Medical Case Reports|April 11, 2008
Elevated maternal lipoprotein (a) and neonatal renal vein thrombosis: a case reportVivek Subbiah, Prabhu Parimi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2023
Reply to S. SorscherVivek Subbiah, Razelle Kurzrock
BMJ Case Reports|May 8, 2019
Molecular imaging of metastatic atrial angiosarcoma with positron emission tomography (PET) tracer 3'-deoxy-3'[<sup>(18)</sup>F]-fluorothymidine, [<sup>(18)</sup>F]-FLT imaging and early response evaluationKalevi Kairemo, Vivek Subbiah
Journal of Immunotherapy and Precision Oncology|June 6, 2022
COVID-19 Pandemic and Cancer Clinical Trial Pandemonium: Finding the Silver LiningAakash Desai, Vivek Subbiah
Nature Reviews. Clinical Oncology|January 27, 2025
Transforming paediatric AML trials: from failing one-size-fits-all methods to precision oncologyBranko Cuglievan, Vivek Subbiah
Pageof 49